Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Dermatan sulfate (DS) is a remarkably versatile glycosaminoglycan that plays critical roles across a wide array of biological processes. Its unique structure, characterized by repeating disaccharide units of -acetyl-D-galactosamine (GalNAc) and Iduronic acid (IdoA) with variable sulfation patterns, enables it to interact with numerous biomolecules. These interactions mediate diverse functions, including the organization of the extracellular matrix, promotion of wound healing, and modulation of cancer progression. Despite its broad biological relevance, deciphering DS function remains challenging due to its pronounced structural complexity and heterogeneity. Variations in chain length, disaccharide composition, and sulfation patterns make it difficult to fully characterize DS's intricate structure-function relationships. In this review, recent developments in biosynthesis, preparation, and applications of DS are summarized.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12384162 | PMC |
| http://dx.doi.org/10.3390/biom15081158 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Congenital disorders caused by aberrations in the biosynthesis of chondroitin/dermatan sulfate.
J Hum Genet
September 2025
Department of Pathobiochemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Chondroitin sulfate (CS)/dermatan sulfate (DS) proteoglycans that play indispensable roles in multiple physiological processes, including cell proliferation, cell adhesion, development, neuronal guidance, and cartilage formation. Depletion of CS/DS caused by biosynthetic enzyme loss of function impairs these processes and results in embryonic lethality. However, some individuals with mutant enzymes survive and exhibit severe phenotypes.
View Article and Find Full Text PDFDermatan Sulfate: Structure, Biosynthesis, and Biological Roles.
Biomolecules
August 2025
National Glycoengineering Research Center, NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-Based Medicine, Shandong Key Laboratory of Carbohydrate and Carbohydrate-Conjugate Drugs, Shandong University, Qingdao 266237, China.
Dermatan sulfate (DS) is a remarkably versatile glycosaminoglycan that plays critical roles across a wide array of biological processes. Its unique structure, characterized by repeating disaccharide units of -acetyl-D-galactosamine (GalNAc) and Iduronic acid (IdoA) with variable sulfation patterns, enables it to interact with numerous biomolecules. These interactions mediate diverse functions, including the organization of the extracellular matrix, promotion of wound healing, and modulation of cancer progression.
View Article and Find Full Text PDFQuantitative HILIC-Q-TOF-MS Analysis of Glycosaminoglycans and Non-reducing End Carbohydrate Biomarkers via Glycan Reductive Isotopic Labeling.
Anal Chem
August 2025
Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602, United States.
Glycosaminoglycans (GAGs) are linear, heterogeneous polysaccharides expressed on all animal cells. Sulfated GAGs, including heparan sulfate (HS) and chondroitin/dermatan sulfate (CS/DS), are involved in numerous physiological and pathological processes; therefore, precise and robust analytical methods for their characterization are essential to correlate structure with function. In this study, we developed a method utilizing hydrophilic interaction liquid chromatography coupled with time-of-flight mass spectrometry (HILIC-Q-TOF-MS) and glycan reductive isotopic reducing end labeling (GRIL) for the quantitative compositional analysis of HS and CS/DS polysaccharides.
View Article and Find Full Text PDFARSK-Related Mucopolysaccharidosis Type 10.
Am J Med Genet A
July 2025
Department of Genetics, College of Medicine and Health Sciences, Sultan Qaboos University Muscat, Muscat, Oman.
Mucopolysaccharidosis type 10 (MPS10) is a recently discovered lysosomal storage disorder caused by biallelic loss of function variants in ARSK. To date, 10 ARSK-related MPS10 patients from six families have been reported, with a median age at presentation of 9.5 years.
View Article and Find Full Text PDFA Novel Sprayable Fibrinogen/Glycosaminoglycans/Collagen-Based Bioink for Skin Wound Healing Applied by a Handheld Dual-Head Airbrush.
Adv Healthc Mater
July 2025
Biopathology and Regenerative Medicine Institute (IBIMER), Center for Biomedical Research (CIBM), University of Granada, Granada, 18016, Spain.
In the last years, different biofabrication methods have gained special attention for the production of skin substitutes that overcome the limitations of conventional skin grafting. Skin sprays represent a promising technology for treating cutaneous wounds as they can deliver both cells and biomaterials to the wound bed in a fast and easy approach, covering extensive wound surfaces. The aim of this study is to develop a novel bioink based on fibrinogen supplemented with a glycosaminoglycans (GAGs)/collagen (Col)-based matrix, containing hyaluronic acid, dermatan sulfate, chondroitin sulfate, and Col, in combination with an innovative dual-head airbrush-based spraying device.
View Article and Find Full Text PDF